ArticleBriefings in bioinformatics2026
Current status of human endogenous retrovirus annotation.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Human endogenous retroviruses (HERVs) constitute a significant fraction of the human genome and are increasingly recognized for their roles in both physiological and pathological processes. Despite their biological importance, the annotation of HERV elements remains inconsistent across major public databases. In this study, we present a comprehensive comparative analysis of three key HERV annotation resources: DFAM, Human Endogenous Retroviruses Database (HERVd), and RepBase. We systematically examine their content, classification schemes, and postprocessing workflows and assess the concordance of their annotations based on genomic coordinates. Our analysis reveals substantial discrepancies in element counts, genome coverage, and repeat fragmentation strategies, which we trace back to differences in curation methodologies-ranging from DFAM's hidden Markov model-based automated detection to HERVd's semimanual defragmentation. Using refined matching criteria, we demonstrate that up to 93% of HERV records can be reconciled across databases, yet each source still contributes a substantial proportion of unique elements. We highlight the complementary strengths of these resources and provide practical recommendations for their usage in HERV research. Our findings underscore the need for harmonized standards in retroelement annotation and may inform future efforts toward unified and comprehensive HERV cataloging, particularly in light of emerging genome assemblies such as T2T-CHM13.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.